Literature DB >> 11730982

Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa.

F Schmitz1, M N Göke, J M Otte, H Schrader, B Reimann, M L Kruse, E G Siegel, J Peters, K H Herzig, U R Fölsch, W E Schmidt.   

Abstract

Gastrin stimulates gastric acid secretion in various species, but the role of the structurally related CCK for the peripheral regulation of acid secretion in humans remains controversial. Moreover, species differences in CCK receptor function and expression have been reported. We therefore sought to identify the cellular targets of CCK and gastrin within the human gastric mucosa in situ. Gastric biopsies were collected from 15 patients without gastric disease. Expression of CCK receptor subtypes was detected in individual cells of the gastric mucosa by reverse transcription (RT)-PCR in situ, immunohistochemistry and confocal laser scanning microscopy, using antisera against the CCK-A or CCK-B/gastrin receptor subtype. Both CCK-A and CCK-B receptors were detected in antral and oxyntic mucosa at the mRNA and protein level. In fundic mucosa, CCK-A receptor mRNA and protein mapped to D cells (37.4+/-7.7). Besides, individual chief cells, mucous neck cells and parietal cells (12.3+/-4.7%) expressed CCK-A receptors. CCK-B/gastrin receptor mRNA and protein were detected in parietal cells (57.4+/-11.1%) and in neuroendocrine cells (33.2+/-4.4%) expressing chromogranin A. Furthermore, epithelial cells within the neck of the gastric gland were found to express the CCK-B/gastrin receptor. We conclude that (i) identification of CCK-A receptors on somatostatin producing D cells in humans provide the anatomical basis for a receptor-mediated mode of action of CCK on somatostatin release and (ii) detection of either CCK receptor subtype in the putative stem cell compartment implies a role of CCK in the maintenance of tissue homeostasis in human gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730982     DOI: 10.1016/s0167-0115(01)00307-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  24 in total

1.  Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects.

Authors:  Malcolm Boyce; Steve Warrington
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

2.  Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.

Authors:  Malcolm Boyce; Steve Warrington; James Black
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

3.  A network map of the gastrin signaling pathway.

Authors:  Yashwanth Subbannayya; Kumari Anuja; Jayshree Advani; Urmesh Kumar Ojha; Vishalakshi Nanjappa; Bijesh George; Avinash Sonawane; Rekha V Kumar; Girija Ramaswamy; Akhilesh Pandey; B L Somani; Rajesh Raju
Journal:  J Cell Commun Signal       Date:  2014-03-02       Impact factor: 5.782

4.  High expression of gastrin receptor protein in injured mucosa of Helicobacter pylori-positive gastritis.

Authors:  Akemi Takamura; Masanori Ito; Tomoyuki Boda; Yoko Matsumoto; Shinji Tanaka; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2012-10-05       Impact factor: 3.199

5.  Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity.

Authors:  Malcolm Boyce; Frans van den Berg; Toni Mitchell; Kate Darwin; Steve Warrington
Journal:  Eur J Clin Pharmacol       Date:  2016-10-29       Impact factor: 2.953

Review 6.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Localization of cholecystokinin receptor subtypes in the endocine pancreas.

Authors:  Jean Morisset; Sophie Julien; Jean Lainé
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

8.  Effect of proton pump inhibitors on glycemic control in patients with diabetes.

Authors:  Kohzo Takebayashi; Toshihiko Inukai
Journal:  World J Diabetes       Date:  2015-08-25

Review 9.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

10.  Control of gastric acid secretion in somatostatin receptor 2 deficient mice: shift from endocrine/paracrine to neurocrine pathways.

Authors:  Chun-Mei Zhao; Vicente Martinez; Laura Piqueras; Lixin Wang; Yvette Taché; Duan Chen
Journal:  Endocrinology       Date:  2007-11-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.